Healthcare
Avalyn Pharma Inc.
AVLN$37.39+5.50%
Price is delayed.
Add to watchlist
About Avalyn Pharma Inc.
Avalyn Pharma is a drug development company working on inhaled medicines for rare lung diseases, particularly pulmonary fibrosis (scarring of lung tissue). Instead of patients taking pills by mouth, the company is developing inhaled versions of existing drugs that deliver medicine directly to the lungs. The company's main experimental treatments combine two anti-scarring medicines that doctors already use to treat progressive lung disease.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore